The antitussive effects of endomorphin-1 and endomorphin-2 in mice

European Journal of Pharmacology

Volumn 467, Issue 1-3, 2003, Pages 219-222

  Kamei, Junzo ^a   Morita, Kayo ^a   Saitoh, Akiyoshi ^a   Nagase, Hiroshi ^b  

^a HOSHI UNIVERSITY   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

Antitussive effect; Cough reflex; Endomorphin 1; Endomorphin 2; Opioid receptor; Opioid receptor

Indexed keywords

ANTITUSSIVE AGENT; BETA FUNALTREXAMINE; CAPSAICIN; ENDOMORPHIN 1; ENDOMORPHIN 2; NALOXONAZINE; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0037466490     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01634-0     Document Type: Article

References (15)

1. Bujdoso E., Jaszberenyi M., Tomboly C., Toth G., Telegdy G. Behavioral and neuroendocrine actions of endomorphin-2. Peptides. 22:2001;1459-1463.
2. Goldberg I.E., Rossi G.C., Letchworth S.R., Mathis J.P., Ryan-Moro J., Leventhal L., Su W., Emmel D., Bolan E.A., Pasternak G.W. Pharmacological characterization of Endomorphin-1 and Endomorphin-2 in mouse brain. J. Pharmacol. Exp. Ther. 286:1998;1007-1013.
3. Haley M.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drug in the conscious mice. Br. J. Pharmacol. 12:1957;12-15.
4. 2-mediated mechanisms in μ-mediated antitussive activity in the mouse. Neurosci. Lett. 149:1993;169-172.
5. 1-opioid receptor-deficient CXBK mice. Eur. J. Pharmacol. 240:1993;99-101.
6. Makulska-Nowak H.E., Gumulka S.W., Lipkowski A.W., Rawa M.A. Effects of endomorphin-2 on arterial blood pressure and pain threshold in spontaneously hypertensive rats and modification of these effects by beta-funaltrexamine and nor-binaltorphimine. Life Sci. 69:2001;581-589.
7. Mehta A., Bot G., Reisine T., Chesselet M.F. Endomorphin-1: induction of motor behavior and lack of receptor desensitization. J. Neurosci. 21:2001;4436-4442.
8. Moskowitz A.S., Goodman R.R. Autoradiographic distribution of mu1 and mu2 opioid binding in the mouse central nervous system. Brain Res. 360:1985;117-129.
9. 1-opioid receptor subtype on motivational effects induced by the endogenous μ-opioid receptor ligands endomorphin-1 and -2 in the mouse. Neurosci. Lett. 308:2001;17-20.
10. Narita M., Ozaki S., Suzuki T. Endomorphin-induced motivational effect: differential mechanism of endomorphin-1 and endomorphin-2. Jpn. J. Pharmacol. 89:2002;224-228.
11. Pan Y.X., Xu J., Bolan E., Chang A., Mahurter L., Rossi G., Pasternak G.W. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F. FEBS Lett. 466:2000;337-340.
12. Rossi G.C., Pan Y.X., Brown G.P., Pasternak G.W. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor. FEBS Lett. 369:1995;192-196.
13. Ukai M., Lin H.P. Endomorphins-1 and -2 induce amnesia via selective modulation of dopamine receptors in mice. Eur. J. Pharmacol. 446:2002;97-101.
14. Zadina J.E., Hackler L., Ge L.-J., Kastin A.J. A potent and selective endogenous agonist for the μ opiate receptor. Nature. 386:1997;499-502.
15. Zangen A., Ikemoto S., Zadina J.E., Wise R.A. Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens. J. Neurosci. 22:2002;7225-7233.